Novotech Backs GoGive1 Vaccine Campaign

Hong Kong - Novotech, a leading biotech specialist CRO in the Asia-Pacific region, with more than 2,000 staff globally, has joined the GoGive1 campaign, where for every fully vaccinated team member a vaccine is donated to a person in a lower income country.

A recent company-wide survey showed 95% of team members have had at least 1 dose or plan to be vaccinated. 

Novotech joined the GoGive1 campaign, backed by the WHO Foundation and GAVI, as part of the company’s COVID-19 safe workplace initiative.

The Novotech workplace policy requires team members who work in the office, visit sites or travel to provide evidence that they have been fully vaccinated. 

Novotech CEO John Moller said:

“Providing a safe working environment for staff is a priority for all employers around the world, and at Novotech we have an additional duty to protect the healthcare workers and patients at the sites we visit.

Our COVID-19 vaccination policy supports our objective of reaching full vaccination across the company.  

Our approach considers local vaccine availability and rollout, and we are funding vaccinations for Team Members where there is limited government support or to accelerate the vaccination process. 

As part of this program, Novotech is donating one vaccine for every fully vaccinated team member, to a lower income country via the WHO and GAVI GoGive1 initiative.”

Novotech’s Chief People Officer, Angela Edwardson said:

“Since vaccines have become available, we have strongly encouraged our Team Members to get vaccinated. 

We have overwhelming support for our company policy that employees should be fully vaccinated on their return to the office. Meanwhile our flexible work options will also allow unvaccinated employees to work remotely as we transition. 

We look forward to welcoming teams back to the office as restrictions ease across our regions.” 

Our key initiatives

  • Novotech is funding vaccination for team members in countries that have limited government support, or to accelerate the vaccination process. 
  • Team members who work in the office, visit sites or travel will need to provide evidence that they have been fully vaccinated or have received a negative test result. 
  • Policy implementation will be phased and dependent on vaccine rollout and availability in each location 
  • Novotech’s flexible working options facilitate Team Members to receive their vaccinations during normal working hours 

Novotech’s vaccine donation and matching programs

 Novotech Backs GoGive1 Vaccine Campaign as Part of Company-wide COVID Safe Workplace Initiative


Go Give 1 incentive program

For every fully vaccinated team member, Novotech will donate 1 Vaccine via the GoGive1 program. GoGive1 was created by the WHO Foundation and GAVI ( Novotech has the potential to contribute over 2,000 vaccinations via this program

Donation Matching Program 

In May 2021, Novotech ran a donation matching initiative, matching all employee donations to, to provide urgent funding to India during the peak of their COVID-19 outbreak.

Media contact

데이빗 제임스 (David James)

언론 연락처

Novotech 기업 소개

1997년 설립된 노보텍은 글로벌 풀서비스 CRO이며 바이오텍과의 파트너십을 통해 임상의 모든 단계에서 혁신적이면서도 새로운 치료제 개발을 가속화하는데 주력하고 있습니다. 

CRO 업계를 주도적으로 이끌어온 공로를 인정받은 노보텍은 2006년부터 CRO Leadership Award 2023, Best Cell & Gene Therapy CRO 2023 상, Asia-Pacific Contract Research Organization Company of the Year Award 2023 등 다수의 권위 있는 상을 수상하였습니다. 

노보텍은 연구소, 임상 1상 시험 기관, 약물 개발 컨설팅 서비스, FDA 규제 전문성을 갖춘 임상 CRO 기업으로 1상에서 4상까지의 임상시험과 생물학적 동등성 연구를 포함해 5,000건 이상의 임상 프로젝트에 참여한 경험이 있습니다. 노보텍은 전 세계 지역에 걸쳐 34개 오피스와 3,000명 이상의 직원을 보유하고 있으며 신뢰할 수 있는 완전한 형태의 전략 파트너입니다. 

보다 더 자세한 정보를 원하거나 전문가 팀에게 문의할 사항이 있을 경우, 회사 홈페이지(를 방문하시기 바랍니다. 

기타 관련 콘텐츠